405 related articles for article (PubMed ID: 30953539)
1. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.
Eissa MAL; Lerner L; Abdelfatah E; Shankar N; Canner JK; Hasan NM; Yaghoobi V; Huang B; Kerner Z; Takaesu F; Wolfgang C; Kwak R; Ruiz M; Tam M; Pisanic TR; Iacobuzio-Donahue CA; Hruban RH; He J; Wang TH; Wood LD; Sharma A; Ahuja N
Clin Epigenetics; 2019 Apr; 11(1):59. PubMed ID: 30953539
[TBL] [Abstract][Full Text] [Related]
2. Novel methylation biomarker panel for the early detection of pancreatic cancer.
Yi JM; Guzzetta AA; Bailey VJ; Downing SR; Van Neste L; Chiappinelli KB; Keeley BP; Stark A; Herrera A; Wolfgang C; Pappou EP; Iacobuzio-Donahue CA; Goggins MG; Herman JG; Wang TH; Baylin SB; Ahuja N
Clin Cancer Res; 2013 Dec; 19(23):6544-6555. PubMed ID: 24088737
[TBL] [Abstract][Full Text] [Related]
3. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer.
Ying L; Sharma A; Chhoda A; Ruzgar N; Hasan N; Kwak R; Wolfgang CL; Wang TH; Kunstman JW; Salem RR; Wood LD; Iacobuzio-Donahue C; Schneider EB; Farrell JJ; Ahuja N
Pancreas; 2021 Oct; 50(9):1267-1273. PubMed ID: 34860810
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
5. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms.
Chhoda A; Sharma A; Sailo B; Tang H; Ruzgar N; Tan WY; Ying L; Khatri R; Narayanan A; Mane S; De Kumar B; Wood LD; Iacobuzio-Donahue C; Wolfgang CL; Kunstman JW; Salem RR; Farrell JJ; Ahuja N
Clin Epigenetics; 2023 Feb; 15(1):28. PubMed ID: 36803844
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Pedersen IS; Krarup H; Thorlacius-Ussing O
Int J Cancer; 2017 Dec; 141(12):2489-2497. PubMed ID: 28857158
[TBL] [Abstract][Full Text] [Related]
8. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
9. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
10. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
Ben-Ami R; Wang QL; Zhang J; Supplee JG; Fahrmann JF; Lehmann-Werman R; Brais LK; Nowak J; Yuan C; Loftus M; Babic A; Irajizad E; Davidi T; Zick A; Hubert A; Neiman D; Piyanzin S; Gal-Rosenberg O; Horn A; Shemer R; Glaser B; Boos N; Jajoo K; Lee L; Clancy TE; Rubinson DA; Ng K; Chabot JA; Kastrinos F; Kluger M; Aguirre AJ; Jänne PA; Bardeesy N; Stanger B; O'Hara MH; Till J; Maitra A; Carpenter EL; Bullock AJ; Genkinger J; Hanash SM; Paweletz CP; Dor Y; Wolpin BM
Gut; 2024 Mar; 73(4):639-648. PubMed ID: 38123998
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
12. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
13. Combination of CA19-9 and Blood Free-Circulating Methylated RUNX3 May Be Useful to Diagnose Stage I Pancreatic Cancer.
Fujimoto Y; Suehiro Y; Kaino S; Suenaga S; Tsuyama T; Matsui H; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Takami T; Nagano H; Sakaida I; Yamasaki T
Oncology; 2021; 99(4):234-239. PubMed ID: 33440396
[TBL] [Abstract][Full Text] [Related]
14. Precision oncology: Artificial intelligence, circulating cell-free DNA, and the minimally invasive detection of pancreatic cancer-A pilot study.
Bahado-Singh RO; Turkoglu O; Aydas B; Vishweswaraiah S
Cancer Med; 2023 Oct; 12(19):19644-19655. PubMed ID: 37787018
[TBL] [Abstract][Full Text] [Related]
15. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
16. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
17. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
18. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
[TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.
Wu Y; Zhang X; Liu Y; Lu F; Chen X
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821013
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
